Abbvie Inc. vs West Pharmaceutical Services, Inc.
ABBV vs WST — side-by-side comparison from reported financials. ABBV leads 4, WST leads 6 of 10 comparable metrics.
Abbvie Inc.
ABBV · Healthcare
$276.43+1.47%Mixed
West Pharmaceutical Services, Inc.
WST · Healthcare
$366.00+0.75%Mixed
| Metric | ABBV | WST |
|---|---|---|
| Price | $276.43 | $366.00 |
| Market cap | $488B | $25.8B |
| Revenue (TTM) | $64.4B | $3.33B |
| Revenue growth | +1.8% | +2.1% |
| Net margin | 9.8% | 17.0% |
| Free cash flow | $18.2B | $437M |
| Net cash (debt) | ($56.2B) | $589M |
| 1-year price return | +19.8% | +38.9% |
| P/E | 77.4 | 47.7 |
| P/E vs own history (cheap-side %) | 23% | 39% |
| Dividend yield | 2.45% | 0.23% |
| Return on equity | 96% | 19% |
| Altman Z-score | 2.33 | — |
| CV checks passed | 9 of 11 | 9 of 11 |
| Employees | 57,000 | 10,800 |
Full résumé-style profiles: ABBV CV · WST CV
Green marks the stronger side on comparable metrics. Figures are derived from company filings and may be delayed, restated or incomplete — information, not investment advice.